Investigational monthly weight-loss injection guide By VerifiedSupps Editorial Team MariTide for Weight Loss: Monthly Injection, Results, and Current Status MariTide is an investigational long-acting weight-loss medication designed for monthly or less frequent injection. In Phase 2, it produced substantial weight
GLP-1 plus glucagon weight-loss medication guide By VerifiedSupps Editorial Team Mazdutide for Weight Loss: Results, Side Effects, and How It Works Mazdutide is a once-weekly GLP-1/glucagon dual receptor agonist that has shown meaningful weight-loss results in Chinese clinical trials. It
Investigational GLP-1 plus glucagon liver and weight-loss guide By VerifiedSupps Editorial Team Pemvidutide for Weight Loss and Fatty Liver: Results, Side Effects, and Current Status Pemvidutide is an investigational once-weekly injectable GLP-1/glucagon dual receptor agonist being studied for obesity, metabolic
Investigational sleep peptide evidence review By VerifiedSupps Editorial Team DSIP Peptide: Sleep, Stress, and What the Evidence Actually Shows DSIP, short for delta sleep-inducing peptide, sounds like a direct answer for poor sleep. The evidence is much less direct: human
Investigational amylin peptide weight-loss guide By VerifiedSupps Editorial Team Cagrilintide for Weight Loss: The Amylin Peptide Behind CagriSema Cagrilintide is an investigational long-acting amylin analogue being studied for weight management. It matters because it is the amylin component inside CagriSema,
Investigational GLP-1 plus amylin weight-loss medication guide By VerifiedSupps Editorial Team CagriSema for Weight Loss: Results, Setbacks, and Current Status CagriSema is an investigational once-weekly injectable combination of cagrilintide, an amylin analogue, and semaglutide, a GLP-1 receptor agonist. In Phase
Investigational amylin weight-loss medication guide By VerifiedSupps Editorial Team Eloralintide for Weight Loss: Results, Side Effects, and Why Amylin Matters Eloralintide is an investigational once-weekly amylin receptor agonist being studied for obesity and weight management. The early signal is strong:
Investigational weight-loss medication guide By VerifiedSupps Editorial Team Survodutide for Weight Loss: Results, Side Effects, and Current Status Survodutide is an investigational once-weekly injectable medication being studied for obesity and metabolic health. The topline Phase III results look meaningful, but
Amylin-based obesity medicine Weight loss with tolerability focus By VerifiedSupps Editorial Team Petrelintide for Weight Loss: Results, Side Effects, and What Makes It Different Petrelintide is one of the more interesting next-wave obesity drugs because it is not another GLP-1.
Next-generation obesity medicine GLP-1 + amylin receptor agonist By VerifiedSupps Editorial Team Amycretin for Weight Loss: Results, Side Effects, and Current Status Amycretin is one of Novo Nordisk’s most closely watched next-generation obesity drugs because it combines GLP-1 and amylin